EFS of the CardioMech MVRS

NCT ID: NCT04820764

Last Updated: 2026-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-27

Study Completion Date

2031-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of the clinical study is to obtain clinical data on the CardioMech Mitral Valve Repair System (MVRS) in patients diagnosed with moderate to severe (≥3+) or severe (≥4+), symptomatic, degenerative mitral regurgitation and who are determined to be at intermediate or high surgical risk for mitral valve repair, as assessed by the site's multidisciplinary heart team.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mitral Regurgitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CardioMech Mitral Valve Repair System (MVRS)

Group Type EXPERIMENTAL

CardioMech MVRS

Intervention Type DEVICE

CardioMech MVRS

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CardioMech MVRS

CardioMech MVRS

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Eighteen (18) years of age or greater
* Moderate to severe (≥3+) or severe (≥4+) mitral valve regurgitation (per American Society of Echocardiography (ASE) guidelines) due to mitral valve prolapse or flail
* Intermediate or high surgical risk for mitral valve repair

Exclusion Criteria

* History of rheumatic heart disease
* History of prior endocarditis
* History of prior repair or replacement of the mitral valve, or annuloplasty
* Severely calcified mitral leaflet or has evidence of calcification in the grasping area of the leaflets that would prevent leaflet anchor positioning and deployment
* Complex mechanism of MR (leaflet perforation, severe leaflet calcifications, commissural extension, commissural prolapse, multiple flail or prolapsing segments, cleft) present on required imaging
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CardioMech AS

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mathew Williams, MD

Role: PRINCIPAL_INVESTIGATOR

NYU Langone

Mayra Guerrero, MD

Role: PRINCIPAL_INVESTIGATOR

Mayo Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cardiovascular Institute of Los Robles Health System

Thousand Oaks, California, United States

Site Status ACTIVE_NOT_RECRUITING

Northwestern University

Evanston, Illinois, United States

Site Status RECRUITING

Ascension St. Francis via Christi

Wichita, Kansas, United States

Site Status RECRUITING

Mayo Clinic

Rochester, Minnesota, United States

Site Status ACTIVE_NOT_RECRUITING

CentraCare Heart & Vascular Center

Saint Cloud, Minnesota, United States

Site Status RECRUITING

NYU Langone

New York, New York, United States

Site Status RECRUITING

Atrium Health Sanger Heart and Vascular Institute

Charlotte, North Carolina, United States

Site Status ACTIVE_NOT_RECRUITING

The Christ Hospital

Cincinnati, Ohio, United States

Site Status RECRUITING

Cleveland Clinic

Cleveland, Ohio, United States

Site Status RECRUITING

Ascension St. Thomas West

Nashville, Tennessee, United States

Site Status RECRUITING

Baylor Scott & White, The Heart Hospital

Plano, Texas, United States

Site Status RECRUITING

Intermountain Medical Center

Murray, Utah, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jennifer Ruether

Role: CONTACT

651-248-4440

Rick Nehm

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Justin Cortez

Role: primary

Meredith Thunberg, RN, BSN

Role: primary

Jennifer Humbert

Role: primary

Patricia Kozikowski

Role: primary

Jamie Bley

Role: primary

Shawn McDaniel

Role: primary

Emily Normandin

Role: primary

Jasmine Kennedy

Role: primary

Lexi Maycock

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10228

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PRIMARY Ancillary Substudy
NCT07103733 RECRUITING NA